侵袭性黑色素瘤亚临床扩展的相关临床与病理因素
该回顾性横断面研究纳入216例接受Mohs显微描记手术(MMS)联合MART-1免疫组化评估的侵袭性黑色素瘤,分析亚临床扩展的相关因素。多因素分析显示头颈部定位、既往治疗史、年龄≥65岁及≥1个核分裂/mm²与亚临床扩展相关,危险因素数量越多扩展概率越高。
要点
- 头颈部、既往治疗史、年龄≥65岁及核分裂≥1/mm²与亚临床扩展相关。
- 肿瘤厚度与组织学亚型未显示与亚临床扩展相关。
- 危险因素数量增加时亚临床扩展概率升高,可辅助筛选适合MMS的病例。
核心结论
- 临床与组织学因素可识别亚临床扩展风险较高的侵袭性黑色素瘤,这类病变可能在重建前受益于MMS或类似技术。
研究设计与样本
- 回顾性横断面研究,纳入216例接受MMS联合MART-1免疫组化评估的侵袭性黑色素瘤。
主要发现
- 多因素分析显示头颈部定位OR 3.28(95%CI 1.16-9.32)、既往治疗史OR 4.18(95%CI 1.42-12.32)、年龄≥65岁OR 4.45(95%CI 1.29-15.39)、≥1个核分裂/mm² OR 2.63(95%CI 1.01-6.83)与亚临床扩展相关。
- 肿瘤厚度与组织学亚型与亚临床扩展无关联。
- 亚临床扩展概率随危险因素数量增加,1个因素为9.22%(95%CI 2.57%-15.86%),5个因素为80.32%(95%CI 68.13%-92.51%)。
关键数值与推荐
- 危险因素包括头颈部定位、既往治疗史、年龄≥65岁及≥1个核分裂/mm²。
- 1个危险因素时亚临床扩展概率9.22%(95%CI 2.57%-15.86%),5个危险因素时80.32%(95%CI 68.13%-92.51%)。
临床怎么用
- 可依据头颈部定位、既往治疗史、年龄≥65岁及核分裂≥1/mm²等危险因素评估亚临床扩展风险,辅助决定重建前是否采用MMS或类似技术。
局限性
- 单中心学术机构开展,样本量小,回顾性设计,可能存在转诊偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Indications to treat invasive melanoma with Mohs micrographic surgery (MMS) or analogous techniques with exhaustive microscopic margin assessment have not been defined. OBJECTIVE: Identify clinical and histologic factors associated with subclinical spread of invasive melanoma. METHODS: This retrospective, cross-sectional study evaluated 216 invasive melanomas treated with MMS and melanoma antigen recognized by T cells 1 immunostaining. Logistic regression models were used to correlate clinicopathologic risk factors with subclinical spread and construct a count prediction model. RESULTS: Risk factors associated with subclinical spread by multivariate analysis included tumor localization on the head and neck (OR 3.28, 95% confidence interval [CI] 1.16-9.32), history of previous treatment (OR 4.18, 95% CI 1.42-12.32), age ≥65 (OR 4.45, 95% CI 1.29-15.39), and ≥1 mitoses/mm2 (OR 2.63, 95% CI 1.01-6.83). Tumor thickness and histologic subtype were not associated with subclinical spread. The probability of subclinical spread increased per number of risk factors, ranging from 9.22% (95% CI 2.57%-15.86%) with 1 factor to 80.32% (95% CI 68.13%-92.51%) with 5 factors. LIMITATIONS: This study was conducted at a single academic institution with a small study population using a retrospective study design that was subject to potential referral bias. CONCLUSION: Clinical and histologic factors identify invasive melanomas that are at increased risk for subclinical spread and might benefit from MMS or analogous techniques prior to reconstruction.
引用
- Shin TM, Shaikh WR, Etzkorn JR, et al. Clinical and pathologic factors associated with subclinical spread of invasive melanoma. J Am Acad Dermatol. 2017. PMID: 28139264. doi:10.1016/j.jaad.2016.11.048
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。